NDUFS2
protein-codingNADH:ubiquinone oxidoreductase core subunit S2, the group of NADH:ubiquinone oxidoreductase core subunits
Gene summary
The protein encoded by this gene is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (complex I). Mammalian mitochondrial complex I is composed of at least 43 different subunits, 7 of which are encoded by the mitochondrial genome, and the rest are the products of nuclear genes. The iron-sulfur protein fraction of complex I is made up of 7 subunits, including this gene product. Complex I catalyzes the NADH oxidation with concomitant ubiquinone reduction and proton ejection out of the mitochondria. Mutations in this gene are associated with mitochondrial complex I deficiency. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032611
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *NDUFS2* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of January 18, 2024. *NDUFS2* encodes NADH:ubiquinone oxidoreductase (complex I) iron-sulfur (Fe-S) protein 2, a core subunit of complex I. Defects of this protein lead to complex I deficiency. *NDUFS2* was first reported in relation to autosomal recessive primary mitochondrial disease in 2001 (PMID: 11220739). While various names have been given to the constellation of features seen in those with *NDUFS2*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *NDUFS2* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Of note, *NDUFS2* was previously curated by this GCEP on April 9, 2021 (SOP Version 7) as having a Definitive association with autosomal recessive Leigh syndrome spectrum (LSS). The scope of this current curation encompassed cases of primary mitochondrial disease, which includes cases with LSS. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 12 variants (11 unique missense variants and a frameshift variant expected to result in protein truncation) in eight probands from fives publications (PMIDs: 11220739, 20819849, 22036843, 28031252, 31411514). Clinical features in affected individuals include Leigh syndrome spectrum, optic atrophy, lactic acidosis, cardiomyopathy, and hepatic involvement, and there is at least one reported case with clinical features consistent with Leber Hereditary Optic Neuropathy (PMIDs: 20819849, 22036843, 28031252, 31411514). The mechanism of disease is loss of function. This gene-disease association is also supported by its known biochemical functional, functional alternation in HEK293 cells with *NDUFS2* knockout, as well as model systems in *C.elegans* and mice (PMIDs: 27509854, 33744462, 18178500, 34732887, 31297047, 112788282). In summary, there is definitive evidence to support the relationship between *NDUFS2* and primary mitochondrial disease. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on January 18, 2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0100133
Submitter: Orphanet
Inheritance Pattern: Mitochondrial
Disease ID:MONDO:0010788
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0032611
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009723
Submitter: ClinGen
The relationship between NDUFS2 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of November 23, 2020. The NDUFS2 gene encodes the NADH:ubiquinone oxidoreductase (complex I) core subunit S2. Defects of this protein lead to complex I deficiency. The NDUFS2 gene was first reported in relation to autosomal recessive Leigh syndrome spectrum in 2001 (PMID: 11220739). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 6 variants in 5 cases from 3 publications (PMIDs: 11220739, 20819849, 22036843). Of note, the c.875T>C (p.Met292Thr) variant is speculated to be a hypomorphic allele (found in 2 homozygotes in gnomAD at the time of this gene review). No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by known protein interactions, expression, functional alterations in patient cells, and model organisms (PMIDs: 27509854, 25613900, 14749350, 29526616, 31297047). In summary, there is definitive evidence to support this gene-disease relationship, including that more than three years have elapsed from the first proposal of the association. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on November 23, 2020 (SOP Version 7).
Inheritance Pattern: AR
Disease ID:MONDO:0032611
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0032611
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0032611
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Gastrointestinal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: In Mitochondrial complex I deficiency, nuclear type 5, medical treatment (eg, riboflavin, ubiquinol) may be beneficial, and individuals may have cardiac involvement
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NDUFS2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001377299.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 44 | 53 | |||
| missense | 3 | 5 | 103 | 6 | 1 | 118 |
| nonsense | 2 | 3 | 5 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 1 | 3 | ||
| splice donor/acceptor (+/-2bp) | 3 | 4 | 7 | |||
| Total | 6 | 12 | 117 | 50 | 1 | 186 |
Highest pathogenic variant AF is 0.0000316
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001364228.1 | 14 | MANE Select | |
| Ensembl | ENSP00000503117.1 | 14 | MANE Select | |
| RefSeq | NP_001159631.1 | 13 | Standard | |
| RefSeq | NP_001364227.1 | 14 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Retrograde endocannabinoid signaling - Homo sapiens (human)
- Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human)
- Alzheimer,s disease - Homo sapiens (human)
- Huntington,s disease - Homo sapiens (human)
- Thermogenesis - Homo sapiens (human)
Biological Process
- mitochondrial electron transport, NADH to ubiquinone
- response to oxidative stress
- mitochondrial respiratory chain complex I assembly
- mitochondrial ATP synthesis coupled electron transport
Molecular Function
- NADH dehydrogenase activity
- protein binding
- NADH dehydrogenase (ubiquinone) activity
- electron transfer activity
- ubiquitin protein ligase binding
Cellular Component
- nucleoplasm
- mitochondrion
- mitochondrial respiratory chain complex I
- mitochondrial matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367993
- Coding exons
- 14
- Length
- 17292
- Individuals with no LoFs
- 125722
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 26
- Defined
- 125748
- p
- 0.000103
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.47 | 192 | 259 | 0.742 | 0.0000153 | 2994 |
| Missense (PolyPhen) | 62 | 122.48 | 0.50619 | 1343 | ||
| Synonymous | -1.18 | 108 | 93.4 | 1.16 | 0.00000476 | 919 |
| Loss of Function | 3.50 | 11 | 32.5 | 0.338 | 0.00000210 | 320 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.000070 | 0.000070 | rare |
| South Asian | 0.00023 | 0.00023 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that is believed to belong to the minimal assembly required for catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (PubMed:12611891). {ECO:0000269|PubMed:12611891}.;
- Disease
- DISEASE: Mitochondrial complex I deficiency (MT-C1D) [MIM:252010]: A disorder of the mitochondrial respiratory chain that causes a wide range of clinical manifestations from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. {ECO:0000269|PubMed:11220739}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.419
Intolerance Scores
- LoFtool
- 0.0524
- RVIS EVS
- 0.49
- RVIS percentile EVS
- 79.38
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.981
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |